Governments have continued to increase their support to the United Nations Habitat and Human Settlements Foundation and to the Technical Cooperation Trust Fund, set up within the framework of the ...
Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human ...
LONDON, ONTARIO--(Marketwire - Feb. 2, 2012) - Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT.V - News) announced today that it has developed Phase 1 oral formulation candidates for COTI-2 ...
LONDON, ONTARIO -- (Marketwire) -- 05/18/11 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has initiated a project to develop an optimal oral formulation of ...
Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match Biodexa Pharmaceuticals PLC (“Biodexa” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results